Zobrazeno 1 - 10
of 69
pro vyhledávání: ''
Autor:
I.A.M. Mandjes, Esther H. Lips, Bas B. Koolen, Lennart Mulder, Sjoerd Rodenhuis, Jelle Wesseling, L. Wessels, J. J. de Ronde
Publikováno v:
Breast Cancer Research and Treatment
Breast cancer research and treatment, 140(1), 63-71. Springer New York
Breast cancer research and treatment, 140(1), 63-71. Springer New York
Intrinsic subtypes are widely accepted for the classification of breast cancer. Lacking gene expression data, surrogate classifications based on immunohistochemistry (IHC) have been proposed. A recent St. Gallen consensus meeting recommends to use th
Autor:
Annemieke Witteveen, Imh Ingrid Vliegen, Joost M. Klaase, Gabe S. Sonke, Maarten Joost IJzerman, Sabine Siesling
Publikováno v:
Breast cancer research and treatment, 152(3), 627-636. Springer
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment
The objective of this study was to develop and validate a time-dependent logistic regression model for prediction of locoregional recurrence (LRR) of breast cancer and a web-based nomogram for clinical decision support. Women first diagnosed with ear
Autor:
Francisca Collado, Pilar Moreo, María Moreno, Dolores Salas-Trejo, Virginia Lope, Beatriz Pérez-Gómez, Francisco Casanova, Francisco Ruiz-Perales, Carmen Pedraz-Pingarrón, Carmen Santamariña, DDM-Spain, Jose Antonio Vázquez-Carrete, Marina Pollán, Carmen Sánchez-Contador, Nieves Ascunce, Nuria Aragonés, Carmen Vidal, Mercé Peris, Josefa Miranda-García, Milagros García
Publikováno v:
Breast Cancer Research and Treatment
High mammographic density (MD) is a phenotype risk marker for breast cancer. Body mass index (BMI) is inversely associated with MD, with the breast being a fat storage site. We investigated the influence of abdominal fat distribution and adult weight
Autor:
Lisa Vandermeer, Stan Z. Gertler, Nathaniel Bouganim, John Hilton, Roanne J. Segal, Daylily S. Ooi, Mark Clemons, G. Dranitsaris, Gregory R. Pond, Susan Dent, Iryna Kuchuk, Eitan Amir, Xinni Song, Sasha Mazzarello, Sean Hopkins, Christina L. Addison
Publikováno v:
Breast Cancer Research and Treatment
The optimal frequency of intravenous (IV) bisphosphonate administration is unclear. We thus performed a study evaluating the effects of switching from 3–4 to 12 weekly therapy in patients with biochemically defined low-risk bone metastases. Patient
Publikováno v:
Breast Cancer Research and Treatment
Numerous breast cancer risk assessment tools that allow users to input personal risk information and obtain a personalized breast cancer risk estimate are available on the Internet. The goal of these tools is to increase screening awareness and ident
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 151(1), 41. Springer New York
Breast Cancer Research and Treatment, 151(1), 41. Springer New York
Promoter hypermethylation of tumor suppressor genes seems to be an early event in breast carcinogenesis and is potentially reversible. This makes methylation a possible therapeutic target, a marker for treatment response and/or a prognostic factor. M
Publikováno v:
Breast Cancer Research and Treatment
A mixed methods, community-based research study was conducted to understand how provider-level factors contribute to the African-American and white disparity in breast cancer mortality in a lower socioeconomic status area of North St. Louis. This stu
Publikováno v:
Breast Cancer Research and Treatment
Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little a
Autor:
Tianfeng Wang, Ai-ping Lu, Yiqiang Liu, Yijun Zhou, Zhaoqing Fan, Tao Ouyang, Yuntao Xie, Jinfeng Li, Yingjian He
Publikováno v:
Breast Cancer Research and Treatment
This study aimed to compare the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer. Five-hundred and one patients with clinical stage I-III invasive breast cancer were randomly assig
Autor:
M E, Cazzaniga, L, Cortesi, A, Ferzi, L, Scaltriti, F, Cicchiello, M, Ciccarese, S, Della Torre, F, Villa, M, Giordano, C, Verusio, M, Nicolini, A R, Gambaro, L, Zanlorenzi, E, Biraghi, L, Legramandi, E, Rulli, Valter, Torri
Publikováno v:
Breast Cancer Research and Treatment
Purpose: The VICTOR-1 study demonstrated that the all-oral metronomic combination of vinorelbine and capecitabine is highly active and well tolerated in hormone receptor-positive/HER2-negative patients. The VICTOR-2 study was designed to confirm thes